Home > Insider Trading > Filing (0001179110-17-010914)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
856982	Merit Medical Systems Inc	MMSI	Surgical & Medical Instruments & Apparatus (3841)	870447695

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1184931	W Richard Edelman	1600 W. Merit Parkway South Jordan UT 84095		No	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, No Par Value	Acquisiton	2017-08-01	20,000	$13.75	35,000	No	4	M	Direct
Common Stock, No Par Value	Disposition	2017-08-01	29,000	$41.19	6,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-qualified stock options (right to buy)	Disposition	2017-08-01	20,000	$0.00	20,000	$13.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2012-08-11	2018-08-11	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Non-qualified stock options (right to buy)	$12.91	2013-05-23	2019-05-23	20,000	20,000	Direct
Common Stock	Non-qualified stock options (right to buy)	$13.99	2015-06-11	2021-06-11	25,000	25,000	Direct
Common Stock	Non-qualified stock options (right to buy)	$20.27	2016-05-22	2022-05-22	25,000	25,000	Direct
Common Stock	Non-qualified stock options (right to buy)	$18.80	2017-05-26	2023-05-26	25,000	25,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2019-05-23	20,000	20,000	Direct
2021-06-11	25,000	25,000	Direct
2022-05-22	25,000	25,000	Direct
2023-05-26	25,000	25,000	Direct

Footnotes

The reporting person ceased to be a director of the Issuer on May 24, 2017.
The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.10 to 41.25, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Became exercisable in equal annual installments of 20% commencing 08/11/2012.
Became exercisable in equal annual installments of 20% commencing 05/23/2013.
Became exercisable in equal annual installments of 20% commencing 06/11/2015. Installments scheduled for vesting after 6/11/2017 will not be exercisable.
Became exercisable in equal annual installments of 20% commencing 05/22/2016. Installments scheduled for vesting after 5/22/2017 will not be exercisable.
Became exercisable in equal annual installments of 20% commencing 05/26/2017. Installments scheduled for vesting after 5/26/2017 will not be exercisable.